Refrigerated - 12 Month(s)/Room Temperature - 12 Month(s)
The THxIDT-BRAF test is intended to be used as an aid in selecting melanoma patients whose tumors carry the BRAF V600E mutation for treatment with debrafenib [Tafinlarr] and as an aid in selecting melanoma patients whose tumors carry the BRAF V600E or V600K mutation for treatment with trametinib [Mekinist(TM)].
Paraffin embedded tissue containing less than 50% tumor cell will
undergo microdissection. If frozen paraffin block is received, call
1(800) 642-4657 ext. 2906.
Reported (Analytical Time)
The CPT codes provided are based on AMA guidelines and are for informational purposes only.
CPT coding is the sole responsibility of the billing party.
Please direct any questions regarding coding to the payer being billed.